[Hereditary C5 deficiency and recurrent Neisseria meningitidis meningitis]. 1988

F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
Unité de néphrologie et de médecine interne, Centre Hospitalier, Annecy.

Deficiencies of the terminal C fragments of the complement system are known to be associated with a remarkable increase in the frequency of Neisseria infections. The correlation is even closer between deficiency of C5 and recurrent N. meningitidis meningitis. The reasons for this bacterial specificity and the immunopathological mechanisms involved have not been clearly established. However, it is known that only adult subjects with homozygous deficiency are affected and that the deficiency is transmitted as an autosomal recessive trait unrelated to the HLA system.

UI MeSH Term Description Entries
D008585 Meningitis, Meningococcal A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
December 1985, Presse medicale (Paris, France : 1983),
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
September 1994, The Journal of infection,
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
January 1992, Revue neurologique,
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
November 1984, Presse medicale (Paris, France : 1983),
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
August 2014, Anales de pediatria (Barcelona, Spain : 2003),
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
January 1999, Medecine tropicale : revue du Corps de sante colonial,
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
June 2007, Lancet (London, England),
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
January 1981, New York state journal of medicine,
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
November 2008, La Tunisie medicale,
F Ducret, and M Decoux, and P Pointet, and C Lambert, and E Grosperrin, and A Sédaillan
February 2001, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!